PMC:7381711 / 4483-4720
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T46 | 27-34 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
| T47 | 132-139 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
| T48 | 143-149 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 131 | 169-185 | Gene | denotes | antithrombin-III | Gene:462 |
| 132 | 187-190 | Gene | denotes | AT3 | Gene:462 |
| 147 | 27-34 | Chemical | denotes | heparin | MESH:D006493 |
| 148 | 75-90 | Chemical | denotes | pentasaccharide | |
| 149 | 132-139 | Chemical | denotes | heparin | MESH:D006493 |
| 150 | 143-149 | Chemical | denotes | serine | MESH:D012694 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T79 | 27-34 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T80 | 75-90 | Chemical | denotes | pentasaccharide | http://purl.obolibrary.org/obo/CHEBI_35369 |
| T81 | 132-139 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T82 | 143-168 | Chemical | denotes | serine protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_64926 |
| T83 | 143-149 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
| T84 | 150-168 | Chemical | denotes | protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
| T86 | 159-168 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T87 | 216-229 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 0-237 | Sentence | denotes | The charge distribution of heparin imparted by the presence of the precise pentasaccharide sequence shown allows for the binding of heparin to serine protease inhibitor antithrombin-III (AT3), conferring its primary anticoagulant effect. |